Vivek Ramaswamy, 10% Owner at Roivant Sciences Ltd. (ROIV), sold 1,295,660 shares at $11.34 ($14.7M) on 2025-06-04, disclosed to the SEC on 2025-06-06.
Open-market sale of $14.7M ROIV by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.34 | 547,430 | $6.2M | 42.3% |
| 2 | $11.34 | 547,430 | $6.2M | 42.3% |
| 3 | $11.19 | 200,800 | $2.2M | 15.3% |
| Total | $11.32 avg | 1,295,660 | $14.7M | 100% |
| Filing → |
| ROIV | SELL | 2025-09-05 | $30.0M | — | Filing → |
| ROIV | SELL | 2025-06-23 | $26.2M | — | Filing → |
| ROIV | SELL | 2025-05-08 | $13.3M | — | Filing → |